Relmada Therapeutics, Inc.

News

Latest Press Releases, Articles & Media Resources

Press Releases

February 15, 2017
Relmada Therapeutics to Participate in the 2nd Annual Disruptive Growth & Healthcare Conference

Company Presentation on February 16, 2017 at 1:45pm ET NEW YORK, Feb. 15, 2017 /PRNewswire/ --┬áRelmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Sergio Traversa, CEO of Relmada Therapeutics, will be presenting at the 2nd Annual Disruptive Growth & Healthcare Conference… Read More ┬╗

More Press Releases

Twitter

View All Tweets